Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
IntroductionWhile allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a curative regimen for acute myeloid leukemia (AML), relapse of read more AML remains a serious risk post-transplantation.Once relapsed, salvage options are limited and management of AML is difficult.Here we designed a prospective study to examine the efficacy a